219 related articles for article (PubMed ID: 33240524)
21. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.
Luo X; Feurstein S; Mohan S; Porter CC; Jackson SA; Keel S; Chicka M; Brown AL; Kesserwan C; Agarwal A; Luo M; Li Z; Ross JE; Baliakas P; Pineda-Alvarez D; DiNardo CD; Bertuch AA; Mehta N; Vulliamy T; Wang Y; Nichols KE; Malcovati L; Walsh MF; Rawlings LH; McWeeney SK; Soulier J; Raimbault A; Routbort MJ; Zhang L; Ryan G; Speck NA; Plon SE; Wu D; Godley LA
Blood Adv; 2019 Oct; 3(20):2962-2979. PubMed ID: 31648317
[TBL] [Abstract][Full Text] [Related]
22. Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.
Spier I; Yin X; Richardson M; Pineda M; Laner A; Ritter D; Boyle J; Mur P; Hansen TVO; Shi X; Mahmood K; Plazzer JP; Ognedal E; Nordling M; Farrington SM; Yamamoto G; Baert-Desurmont S; Martins A; Borras E; Tops C; Webb E; Beshay V; Genuardi M; Pesaran T; Capellá G; Tavtigian SV; Latchford A; Frayling IM; Plon SE; Greenblatt M; Macrae FA; Aretz S;
Genet Med; 2024 Feb; 26(2):100992. PubMed ID: 37800450
[TBL] [Abstract][Full Text] [Related]
23. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
24. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
[TBL] [Abstract][Full Text] [Related]
25. Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.
Dumbrava EI; Brusco L; Daniels M; Wathoo C; Shaw K; Lu K; Zheng X; Strong L; Litton J; Arun B; Eterovic AK; Routbort M; Patel K; Qi Y; Piha-Paul S; Subbiah V; Hong D; Rodon J; Kopetz S; Mendelsohn J; Mills GB; Chen K; Meric-Bernstam F
JCO Precis Oncol; 2019; 3():. PubMed ID: 31517177
[TBL] [Abstract][Full Text] [Related]
26. Diagnostics of
Sculco M; La Vecchia M; Aspesi A; Clavenna MG; Salvo M; Borgonovi G; Pittaro A; Witel G; Napoli F; Listì A; Grosso F; Libener R; Maconi A; Rena O; Boldorini R; Giachino D; Bironzo P; Maffè A; Alì G; Elefanti L; Menin C; Righi L; Tampieri C; Scagliotti GV; Dianzani C; Ferrante D; Migliore E; Magnani C; Mirabelli D; Matullo G; Dianzani I
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885614
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
28. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
[TBL] [Abstract][Full Text] [Related]
29. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
[TBL] [Abstract][Full Text] [Related]
30. Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.
Cheung M; Kadariya Y; Sementino E; Hall MJ; Cozzi I; Ascoli V; Ohar JA; Testa JR
Hum Mol Genet; 2021 Aug; 30(18):1750-1761. PubMed ID: 34008015
[TBL] [Abstract][Full Text] [Related]
31. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract][Full Text] [Related]
32. Oncologist-led germline genetic testing for uveal melanoma.
Gillies B; Krema H; Chao A; Lando L; Farncombe KM; Butler M; Altomare F; Kim RH
Ophthalmic Genet; 2023 Jun; 44(3):253-261. PubMed ID: 36974392
[TBL] [Abstract][Full Text] [Related]
33. Mesothelioma developing in carriers of inherited genetic mutations.
Yoshikawa Y; Emi M; Nakano T; Gaudino G
Transl Lung Cancer Res; 2020 Feb; 9(Suppl 1):S67-S76. PubMed ID: 32206572
[TBL] [Abstract][Full Text] [Related]
34. Puzzling Results from
Rizzardi C; Athanasakis E; Cammisuli F; Monego SD; DE Spelorzi YCC; Costantinides F; Giudici F; Pinamonti M; Canzonieri V; Melato M; Pascolo L
Anticancer Res; 2017 Jun; 37(6):3073-3083. PubMed ID: 28551647
[TBL] [Abstract][Full Text] [Related]
35. Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Sorbye H; Elvebakken H; Perren A; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Ladekarl M; Tabaksblat EM; Knappskog S
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410378
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1.
Mur P; Viana-Errasti J; García-Mulero S; Magraner-Pardo L; Muñoz IG; Pons T; Capellá G; Pineda M; Feliubadaló L; Valle L
Genome Med; 2023 Oct; 15(1):85. PubMed ID: 37848928
[TBL] [Abstract][Full Text] [Related]
37. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
38. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T
Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627
[TBL] [Abstract][Full Text] [Related]
39. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.
Pastorino S; Yoshikawa Y; Pass HI; Emi M; Nasu M; Pagano I; Takinishi Y; Yamamoto R; Minaai M; Hashimoto-Tamaoki T; Ohmuraya M; Goto K; Goparaju C; Sarin KY; Tanji M; Bononi A; Napolitano A; Gaudino G; Hesdorffer M; Yang H; Carbone M
J Clin Oncol; 2018 Oct; 36(35):JCO2018790352. PubMed ID: 30376426
[TBL] [Abstract][Full Text] [Related]
40. Common, germline genetic variations in the novel tumor suppressor
Lin M; Zhang L; Hildebrandt MAT; Huang M; Wu X; Ye Y
Oncotarget; 2017 Sep; 8(43):74936-74946. PubMed ID: 29088836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
